National Institutes of Health logo
NIH Research Project Cooperative Agreement (U01)

NIDCD Cooperative Agreement for Clinical Trials in Communication Disorders

Funds a clinical trial for a communication disorder that NIH runs jointly with the investigator, when the trial meets a high-oversight or high-risk bar.

OpenNational Institutes of HealthUnited States

Some communication-disorder trials carry more weight than others — a drug or approach headed toward FDA approval, or one that could cause real harm if the science is wrong. For those, NIH does not just write a check; it puts one of its own scientists inside the project.

This is a cooperative agreement between an NIDCD Project Scientist and an investigator, built around a single clinical trial for…

A cooperative agreement between an NIDCD Project Scientist and an investigator supporting a single clinical trial for the treatment or prevention of a communication disorder, where the trial requires FDA oversight, is intended to formally establish efficacy, or carries a higher risk of physical or psychological harm. A clinical trial is required.

CycleiHow often this grant runs — e.g. annually, on a rolling basis, or a one-off call.Multiple per year
Next deadlineiThe next date applications are due. Rolling means you can apply any time.18 Oct 2027
Decision timeiTypical time from the deadline to the funder's decision.26 weeks
Project durationiHow long the funded work is expected to run.—
Award typeiThe form of funding — grant, equity, loan, tax credit, etc.Cooperative agreement
Match fundingiThe share of project costs you must cover yourself. 0% = fully funded.—
Funding pooliThe total budget available across all awards in this round.—

Sign up free to see the funding breakdown

Sign up free to see the industries in scope

Sign up free to see the full eligibility

Sign up free to see how to apply

Sign up free to see what you submit

Sign up free to see how they score you

Sign up free to see the timeline

Sign up free to see where teams trip up

Last verified: 25 Aug 2026Funder reference: PAR-25-343Source: www.grants.gov